ALLAPININE USE FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS: CURRENT ASPECTS

Download full text PDF
Issue: 
2
Year: 
2015

T. Potupchik (1), Candidate of Medical Sciences; O. Veselova (1), Candidate of Medical Sciences; L. Evert (2), MD; E. Ilkova (3) 1 -Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University 2 -Research Institute for Medical Problems of the North, Krasnoyarsk 3 -M Hospital One, Lesosibirsk

The paper gives an update on the use of the Class IC antiarrhythmic Allapinine (lappaconitine hydrobromide).

Keywords: 
ventricular premature beats
ventricular tachycardias
atrial fibrillation
lappaconitine hydrobromide
Allapinine



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Balykova L.A., Nazarova I.S., Tishina A.N. Lechenie aritmij serdtsa u detej // Praktich. meditsina. – 2011; 5: 25–32.
  2. Bojarintsev V.V., Alekseeva L.A., Stazhadze L.L. i dr. Vpervye zaregistrirovannaja fibrilljatsija predserdij: osobennosti klinicheskogo techenija, lechenija i prognoz // Kardiologija. – 2013; 2: 29.
  3. Golitsin S.P. Grani pol'zy i riska pri lechenii zheludochkovyh narushenij ritma serdtsa // Mezhdunarodnyj zhurn. med. prakt. – 2000; 10: 56–64.
  4. Dmitrieva O.A. Puti optimizatsii terapii Allapininom pri narushenijah ritma i provodimosti serdtsa. Avtoref. dis. ... kand. med. nauk. Saransk, 2012; 25 s.
  5. Zamotaev Ju.N., Kremnev Ju.A., Grinenko N.A. i dr. Otsenka effektivnosti preparata Allapinin u bol'nyh IBS s narushenijami ritma serdtsa pri ispol'zovanii sutochnogo EKG-monitorirovanija v kachestve informativnogo metoda kontrolja // Rus. med. zhurn. – 2003; 9 (11): 14–20.
  6. Kanorskij S.G. Antiaritmicheskaja terapija u patsientov s paroksizmalnoj i persistirujuschej formami fibrilljatsii predserdij: opredelenie dostizhimoj tseli i otsenka imejuschihsja sredstv // Kardiologija. – 2014; 2: 70–3.
  7. Kotljarov A.A., Mosina L.M., Chibisov S.M. i dr. Antiaritmicheskaja terapija paroksizmal'nyh tahikardij i ekstrasistolij u bol'nyh s dis-funktsiej sinusovogo uzla // Klin. meditsina. – 2012; 9: 57–9
  8. Mel'nik M. Opyt primenenija lappakonitina gidrobromida (Allapinina) u patsienta posle uspeshnoj reanimatsii po povodu fibrillja-tsii zheludochkov // Vrach. – 2014; 11: 66–8.
  9. Natsional'nye rekomendatsii po opredeleniju riska i profilaktike vnezapnoj serdechnoj smerti // Klin. praktika. – 2012; 4: 1–94.
  10. Rahmanova M.M., Sokolov S.F. Effektivnost' Allapinina v sravnnii s hinidina biosul'fatom dlja preduprezhdenija retsidivov persistiruju-schej fibrilljatsii predserdij posle vosstanovlenija sinusovogo ritma // Kardiologija. – 2014; 7: 33–7.
  11. Sokolov S.F. Allapinin i sovremennye podhody k lecheniju narushenij ritma serdtsa: Metod. rekomend. po primeneniju preparata / M.: FGU RKNPK Rosmedtehnologij, 2013; 35 s.
  12. Sokolov S.F. Rezul'taty klinicheskogo izuchenija preparata Allapinin i sovremennye podhody k lecheniju bol'nyh s narushenijami ritma serdtsa // Vestn. aritmologii. – 2011; 64: 60–70.
  13. Sokolov S.F. Sovremennye podhody k lecheniju bol'nyh s narushenija-13. mi serdechnogo ritma serdtsa i rezul'taty klinicheskogo izuchenija preparata Allapinin // Narushenija ritma serdtsa. – 2011; 3: 1–13.
  14. Sokolov S.F., Bakalov S.A., Mironova N.A. i dr. Effektivnost' i bezopasnost' Allapinina pri kratkosrochnom i dlitel'nom lechenii bol'nyh s dobrokachestvennoj zheludochkovoj ekstrasistolii // Kardiologija. – 2014; 1: 20–6.
  15. Tatarskij B.A. Protektornaja terapija fibrilljatsii predserdij bloka- torom pozdnih natrievyh kanalov (pilotnoe issledovanie) // Serdtse: zhurnal dlja praktikujuschih vrachej. – 2014; 2: 123–8.
  16. Junusov V., Nikolaeva I., Plechev V. i dr. Opyt primenenija v perioperatsionnom periode koronarnogo shuntirovanija // Vrach. – 2014; 10: 64–71.
  17. Fuster V., Ryden L., Cannom D. et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) // Circulation. – 2006; 114: 257–354.
  18. Reiffel J., Ester N., Waldo A. et al. A Consensus report on antiarrhuthmic drug use // Clin. Cardiol. – 1994; 17: 103–16.
  19. Zipes D., Camm A., Borggrefe M. et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) // Circulation. – 2006; 114: 385–484.